Journal of Adolescent Health
Volume 47, Issue 3 , Pages 215-218 , September 2010

Voluntary School-Based Human Papillomavirus Vaccination: An Efficient and Acceptable Model for Achieving High Vaccine Coverage in Adolescents

References 

  1. Muñoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on All HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102:325–339
  2. Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–314
  3. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis. 2005;191(Suppl 1):S97–106
  4. Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology. 2002;13:631–639
  5. Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis. 2004;10:1915–1923
  6. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96:604–615
  7. Smith MA, Canfell K, Brotherton JML, et al. The predicted impact of vaccination on human papillomavirus infections in Australia. Int J Cancer. 2008;123:1854–1863
  8. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ. 2008;336:1056–1058
  9. Brotherton JML, Deeks SL, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell. 2008;32:457–461
  10. Jain N, Euler GL, Shefer A, et al. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007. Prev Med. 2009;48:426–431
  11. Rouzier R, Giordanella J-P. Coverage and compliance of human papillomavirus vaccines in Paris: Demonstration of low compliance with non-school-based approaches. J Adolesc Health. 2010;47:237–241
  12. Rosenthal SL, Weiss TW, Zimet GD, et al. Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine (in press).
  13. Wong C, Berkowitz Z, Dorell C, et al. National HPV vaccine uptake among girls 9-17 years old—National Health Interview Survey, United States, 2008. Conference abstract 10768 in “Children’s Health: Climbing to new Heights;” October 2–5, 2010; San Francisco, CA. Available at: http://aap.confex.com/aap/2010/webprogram/Paper10768.html.
  14. Gross MS, Andres R, Soren K. Human papillomavirus (HPV) vaccination and pap smear results in adolescent girls—Have we seen a difference?. J Pediatr Adolesc Gynecol. 2010;23:70–71
  15. Brotherton JML, Fridman M, Saville M, Gertig D. First indication of a possible impact on cervical abnormalities following a national HPV vaccination program, in Victoria, Australia. Conference abstract in “HPV 2010;” July 2–8, 2010; Montreal, Canada. Available at: http://hpv2010.org/main/index.php?option=com_conference&view=presentation&id=1746&conference=1&Itemid=103.
  16. Orenstein WA, Hinman AR. The immunization system in the United States—The role of school immunization laws. Vaccine. 1999;17(s3):S19–S24
  17. Skinner SR, Imberger A, Nolan T, Lester R, Glover S, Bowes G. Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccination. Aust N Z J Pub Health. 2000;24:298–304
  18. Dobson S, Scheifele D, Bell A. Assessment of a universal school-based hepatitis B vaccination program. J Am Med Assoc. 1995;274:1209–1213
  19. Stroffolini T, Cialdea L, Tosti M, et al. Vaccination campaign against hepatitis B for 12 year old subjects in Italy. Vaccine. 1997;15:583–585
  20. Ogilvie G, Anderson M, Marra F, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7:e1000270
  21. Carpenter L, Lott J, Lawson B, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system. Pediatrics. 2007;120:E172–E178
  22. Goldstein S, Cassidy W, Hodgson W, Mahoney F. Factors associated with student participation in a school-based hepatitis B immunization program. J Sch Health. 2001;71:184–187
  23. Unti L, Coyle K, Woodruff B, Boyer-Chuanroong L. Incentives and motivators in school-based hepatitis B vaccination programs. J Sch Health. 1997;67:265–268
  24. Woodruff B, Unti L, Coyle K, Boyer-Chuanroong L. Parents’ attitudes toward school-based hepatitis B vaccination of their children. Pediatrics. 1996;98:410–413
  25. Dempsey AF, Mendez D. Examining future adolescent HPV vaccine uptake with and without a school mandate. J Adolesc Health. 2010;47:242–248
  26. Udesky L. Push to mandate HPV vaccine triggers backlash in USA. The Lancet. 2007;369:979–980
  27. Haber G, Marlow RM, Zimet GD. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol. 2007;20:325–331
  28. Immunize.org website. Available at: http://www.immunize.org/laws/. Viewed June 21, 2010.
  29. Stokley S, Dorell C, Yankey D. Centers for Disease Control. National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2008. Morb Mortal Wkly Rep. 2009;58:997–1001
  30. NCSL website. Available at: http://www.ncsl.org/IssuesResearch/Health/HPVVaccineStateLegislation/tabid/14381/Default.aspx. Viewed June 16, 2010.
  31. Cates JR, Shafer A, Carpentier FD, et al. How parents hear about human papillomavirus vaccine: Implications for uptake. J Adolesc Health. 2010;47:305–308
  32. Middleman AB, Tung JS. Urban middle school parent perspectives: The vaccines they are willing to have their children receive using school-based immunization programs. J Adolesc Health. 2010;47:249–253
  33. Averhoff F, Linton L, Peddecord KM, et al. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health. 2004;94:978–984
  34. Jacobs RJ, Meyerhoff AS. Effect of middle school entry requirements on hepatitis B vaccination coverage. J Adolesc Health. 2004;34:420–423
  35. Morita JY, Ramirez E, Trick WE. Effect of a school-entry vaccination requirement on racial and ethnic disparities in hepatitis B immunization coverage levels among public school students. Pediatrics. 2008;121:e547–e552
  36. Rand CM, Szilagyi PG, Albertin C, et al. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: A national study. Pediatrics. 2007;120:461–466
  37. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med. 2007;45:107–114
  38. Dempsey AF, Davis MM. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care. 2006;12:S484–S491
  39. Cooper Robbins SC, Bernard D, McCaffery K, Skinner SR. “It’s a logistical nightmare!”: Recommendations for optimizing HPV school-based vaccination experiences. Sex Health (in press).
  40. Watson M, Shaw D, Molchanoff L, et al. Challenges, lessons learned, and results following the implementation of a human papillomavirus school vaccination program in South Australia. Aust NZJ Public Health. 2009;33:365–370
  41. Guajardo A, Middleman A, Sansaricq K. School nurses identify barriers and solutions to implementing a school-based hepatitis B immunization program. J Sch Health. 2002;72:128–130
  42. Stewart P, MacDonald N, Manion I. School-based hepatitis B immunization program: Follow-up of non-participants at first school clinic. Can J Public Health. 1997;88:192–196
  43. NHS Immunisation Website. Available at: www.immunisation.nhs.uk/files/DH_HPV_consent_Mar08.pdf. 2008. Viewed June 30, 2010.
  44. NSW DET Website. Available at: http://www.schools.nsw.edu.au/gotoschool/a-z/immunisation.php. Viewed June 16, 2010.
  45. Rivest P, Grenier L, Lonergan G, Bedard L. Varicella vaccination for grades 4 and 5 students—From theory to practice. Can J Public Health. 2005;96:197–200
  46. Centers for Disease Control . FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59:630–632
  47. Dempsey AF, Freed GL. Health care utilization by adolescents on Medicaid: Implications for delivering vaccines. Pediatrics. 2010;125:43–49

PII: S1054-139X(10)00318-6

doi: 10.1016/j.jadohealth.2010.07.002

Journal of Adolescent Health
Volume 47, Issue 3 , Pages 215-218 , September 2010

Article Tools